Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Reported Revenue Growth — Specialty Diagnostics by Year
Reported Revenue Growth — Specialty Diagnostics (%)
Thermo Fisher Scientific Reported Revenue Growth — Specialty Diagnostics: 4.0% in FY2025, up 2.0 pts from a year earlier.
Where the FY2025 figure comes from
“SD: Total revenue growth 3% 2% 4% 5% 4% -1% 6% -6%”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package & SEC MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Reported Revenue Growth — Specialty Diagnostics (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.0% | +2.0 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 2.0% | +10.0 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | -8.0% | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Reported Revenue Growth — Specialty Diagnostics (%), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-reported-pct-sd
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.